X-150985685-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005342.4(HMGB3):c.86A>G(p.Lys29Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000237 in 1,206,560 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 84 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., 4 hem., cov: 23)
Exomes 𝑓: 0.00024 ( 0 hom. 80 hem. )
Consequence
HMGB3
NM_005342.4 missense
NM_005342.4 missense
Scores
6
11
Clinical Significance
Conservation
PhyloP100: 6.11
Genes affected
HMGB3 (HGNC:5004): (high mobility group box 3) This gene encodes a member of a family of proteins containing one or more high mobility group DNA-binding motifs. The encoded protein plays an important role in maintaining stem cell populations, and may be aberrantly expressed in tumor cells. A mutation in this gene was associated with microphthalmia, syndromic 13. There are numerous pseudogenes of this gene on multiple chromosomes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.23383).
BS2
High Hemizygotes in GnomAd4 at 4 XL gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000205 AC: 23AN: 112437Hom.: 0 Cov.: 23 AF XY: 0.000116 AC XY: 4AN XY: 34585
GnomAD3 genomes
AF:
AC:
23
AN:
112437
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
34585
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000935 AC: 17AN: 181730Hom.: 0 AF XY: 0.0000899 AC XY: 6AN XY: 66752
GnomAD3 exomes
AF:
AC:
17
AN:
181730
Hom.:
AF XY:
AC XY:
6
AN XY:
66752
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000240 AC: 263AN: 1094123Hom.: 0 Cov.: 28 AF XY: 0.000222 AC XY: 80AN XY: 359657
GnomAD4 exome
AF:
AC:
263
AN:
1094123
Hom.:
Cov.:
28
AF XY:
AC XY:
80
AN XY:
359657
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000205 AC: 23AN: 112437Hom.: 0 Cov.: 23 AF XY: 0.000116 AC XY: 4AN XY: 34585
GnomAD4 genome
AF:
AC:
23
AN:
112437
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
34585
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
11
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2022 | The c.86A>G (p.K29R) alteration is located in exon 2 (coding exon 1) of the HMGB3 gene. This alteration results from a A to G substitution at nucleotide position 86, causing the lysine (K) at amino acid position 29 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 28, 2023 | This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 29 of the HMGB3 protein (p.Lys29Arg). This variant is present in population databases (rs150269635, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with HMGB3-related conditions. ClinVar contains an entry for this variant (Variation ID: 2247329). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.;L;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;N
REVEL
Benign
Sift
Benign
D;D;D;D;D
Sift4G
Uncertain
T;T;T;T;T
Polyphen
0.046
.;B;.;B;.
Vest4
0.31
MVP
MPC
0.84
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at